Overview
AI quantifies changes in tumor burden and functional metrics to assess treatment response. Automated assessment enables earlier detection of response or progression. Standardized metrics support clinical trials and practice.
Imaging Biomarkers
Functional imaging and radiomic changes serve as biomarkers of response. AI extracts and integrates these signals for robust assessment. Validation links imaging biomarkers to clinical outcomes.
Workflow
Automated pipelines process serial studies and generate response reports for clinicians. Alerts notify teams of significant changes requiring action. Integration with oncology systems streamlines care coordination.
Regulatory Pathways
Demonstrating clinical benefit and reproducibility is required for regulatory approval. Prospective trials validate AI driven response assessment. Post market monitoring tracks real world performance.